Recent report showed that combination inhibited by MNK inhibitor CGP57380 and mTOR inhibitor RAD001 exert synergistic antitumor efficacy in NSCLC, demonstrated targeting both mTOR and MNK/eIF4E signaling pathways can enhance the treatment27. This evidence concerns the gene EIF4E and non-small cell lung carcinoma.